loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

RAINBOW CHILDRENS MEDICARE SHARE PRICE

Sector Healthcare
BSE 543524
NSE RAINBOW
1,454.70
-18.70 (-1.27 %)
Buy
B
Sell
S
NSE BSE

Overview

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
Day Low

1,447.40

Day High

1,494.90

52 Week Low

1,084.00

52 Week High

1,610.00

All Time Low

410.00

All Time High

1,709.60

Open

1,473.40

Close

1,473.40

Volume

99,805

Mkt cap (Cr)

14,773.79

P/E ratio

50.88

P/B ratio

8.85%

Div yield

0.24%

6M return

29.02%

1Y return

-0.16%

SWOT Analysis

  • S
  • W
  • O
  • T
  • Strength (7)

    Companies with no Debt

  • Weakness (3)

    Stocks which have rising amounts of capital work in progress (CWIP), where costs of long term projects is rising

  • Opportunity (1)

    FII / FPI or Institutions increasing their shareholding

  • Threats (0)
  • Companies with no Debt
  • Increasing Revenue every Quarter for the past 4 Quarters
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years
  • Companies with Zero Promoter Pledge
  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income
  • FII / FPI or Institutions increasing their shareholding
Data not found

Technical Analysis

Moving Averages

EMA SMA
  • 5 Day 1,458.4
  • 10 Day 1,455.8
  • 12 Day 1,455.4
  • 20 Day 1,457.1
  • 26 Day 1,458.9
  • 50 Day 1,454.2
  • 100 Day 1,420.2
  • 200 Day 1,384.2
1,454.70 -1.27%

Current Price

  • Bullish Moving Averages 7
  • Bearish Moving Averages 9

Resistance and support

1,465.67PIVOT
  • First Resistance 1,483.9
  • Second Resistance 1,513.2
  • Third Resistance 1,531.4
  • First Support 1,436.4
  • Second Support 1,418.2
  • Third Support 1,388.9

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
  • CAGR IN 10 YEARS
  • 23.36%
  • 30.73%
  • 34.75%
Mar 2026 (CR)
Mar 2025 (CR)
Mar 2024 (CR)
Mar 2023 (CR)
Mar 2022 (CR)
Sales 1,545.66 1,454.51 1,236.56 1,113.99 924.60
Operating Profit 502.07 478.56 416.75 380.40 298.71
OP Profit Margin 32.48 32.90 33.70 34.15 32.31
Interest 75.14 73.68 59.33 55.09 52.80
Profit After Tax 250.02 237.59 214.89 205.89 142.29
Cash Profit 391.16 370.07 320.39 295.04 222.52
EPS 24.62 23.40 21.17 20.28 15.13
  • CAGR IN 10 YEARS
  • 21.51%
  • 58.05%
  • 32.34%
Mar 2026 (CR)
Mar 2025 (CR)
Mar 2024 (CR)
Mar 2023 (CR)
Mar 2022 (CR)
Equity 101.56 101.55 101.50 101.50 105.00
Reserve Surplus 1,583.70 1,386.99 1,183.75 986.89 531.30
TOT Debts 801.36 734.36 734.70 538.29 547.70
Gross Block 2,195.78 1,973.54 1,693.03 1,259.08 1,095.50
Capital Work In Progress 79.13 28.36 19.92 22.81 5.76
Cash Liquid Investment 17.29 16.91 7.49 37.15 175.15
Net Working Capital 118.67 142.70 196.86 313.82 173.47
Current Assets 293.74 296.92 347.01 555.16 393.49
Current Liabilities 175.07 154.22 150.15 241.33 220.02
Jun 2026 (CR)
Mar 2026 (CR)
Dec 2025 (CR)
Sep 2025 (CR)
Jun 2025 (CR)
Sales 410.55 408.06 394.35 408.50 334.75
Gross Profit 108.17 114.11 123.27 131.58 101.41
Gross Profit Margins 86.68 88.10 87.05 86.27 86.87
Operating Profit 114.66 127.40 130.68 140.72 99.52
OP Profit Margin 21.87 23.77 27.03 28.33 25.75
Interest 19.25 18.52 18.17 17.31 17.39
Profit After Tax 52.71 59.31 65.82 73.17 51.72
Cash Profit 90.34 94.96 100.65 106.35 84.31
EPS 5.20 5.85 6.48 7.20 5.09
  • CAGR IN 10 YEARS
  • 21.51%
  • 58.05%
  • 32.34%
Mar 2026 (CR)
Mar 2025 (CR)
Mar 2024 (CR)
Mar 2023 (CR)
Mar 2022 (CR)
PE 47.25 59.83 61.31 36.00 0.00
P/BV 6.99 9.55 10.25 6.81 0.00
MCAP Sales 7.64 9.77 10.65 6.65 0.00
Asset Turnover 0.65 0.68 0.68 0.79 0.86
EV/EBITDA 23.09 28.31 30.64 19.22 0.00
DEBT/EQUITY 0.48 0.53 0.54 0.63 0.93
ROE 15.74 17.13 18.11 24.03 26.10
ROCE 17.28 18.58 19.04 23.23 22.51

Quick Results Snapshot

Q1FY27 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Healthcare Facilities company Rainbow Childrens Medicare announced Q1FY27 results

Consolidated Financial Highlights:

  • Revenue from operations reached Rs 4,699.85 million in Q1FY27, representing a growth of 33.17% compared to Rs 3,529.29 million in Q1FY26. On a QoQ basis, revenue increased by 2.19% from Rs 4,599.01 million in Q4FY26.
  • Total income for Q1FY27 stood at Rs 4,826.95 million, an increase of 29.43% YoY from Rs 3,729.45 million in Q1FY26 and a growth of 3.81% QoQ from Rs 4,649.65 million in Q4FY26.
  • Profit before tax for Q1FY27 was reported at Rs 839.53 million, up 17.62% YoY from Rs 713.74 million in Q1FY26, while declining by 3.27% sequentially compared to Rs 867.91 million in Q4FY26.
  • Net profit for the period was Rs 625.40 million in Q1FY27, showing a YoY growth of 16.23% from Rs 538.05 million in Q1FY26. On a QoQ basis, net profit registered a decrease of 20.04% compared to Rs 782.18 million in Q4FY26.
  • Earnings per share (Basic) for the quarter stood at Rs 5.97, compared to Rs 5.27 in Q1FY26 and Rs 7.59 in Q4FY26.

Standalone Financial Highlights:

  • Revenue from operations for Q1FY27 was Rs 4,105.47 million, reflecting a YoY growth of 22.64% from Rs 3,347.48 million in Q1FY26 and a marginal QoQ growth of 0.61% from Rs 4,080.64 million in Q4FY26.
  • Total income for the quarter stood at Rs 4,233.04 million, up 19.57% YoY from Rs 3,540.33 million in Q1FY26 and up 2.42% QoQ from Rs 4,133.04 million in Q4FY26.
  • Net profit for Q1FY27 reached Rs 527.06 million, a growth of 1.91% YoY compared to Rs 517.20 million in Q1FY26. Sequentially, net profit declined by 11.13% from Rs 593.05 million in Q4FY26.
  • Earnings per share (Basic) was Rs 5.20 in Q1FY27, compared to Rs 5.09 in Q1FY26.

Business Highlights:

  • Segment wise Performance: The company is primarily engaged in a single business segment of rendering medical and healthcare services. Furthermore, business operations are concentrated within India, representing a single geographical segment.
  • New Hospital Development: Subsequent to the quarter end, the company executed definitive transaction documents for capacity addition through the development of a new children and women's hospital at Malad, Mumbai. This project is being managed through its wholly owned subsidiary, Rainbow Women & Children's Hospital Private Limited.
  • Strategic Acquisition: The company has executed a Partnership Interest and Contribution Transfer Agreement (PICTA) to acquire a 64% partnership interest in Super Prime Medical Care LLP for an aggregate consideration of Rs 198 million. This acquisition involves a running children's hospital at Nellore, Andhra Pradesh, and is expected to be completed in the quarter ended September 30, 2026.
  • Corporate Designation: Mr. Anshuman Jaiswal was elevated from the position of Group Head – Legal to Chief Legal Officer and designated as Senior Management Personnel (SMP) of the company effective July 30, 2026.
  • Dividend Payout: A final dividend for FY26 of Rs 3.50 per equity share, aggregating to Rs 355.48 million, was approved by shareholders at the AGM and paid on July 29, 2026.
  • Stock Options: The company allotted 7,483 equity shares during Q1FY27 following the exercise of stock options under the Employee Stock Unit Plan 2023. Additionally, 267,550 stock options were granted under the ESOP 2025 scheme in May 2026 to eligible employees.

Result PDF

Read More

Q4FY26 & FY26 Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q3FY26 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q2FY26 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q1FY26 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q4FY25 & FY25 Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q3FY25 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q2FY25 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q1FY25 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q4FY24 Quarterly & FY24 Annual Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q3FY24 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q4FY23 Quarterly & FY23 Annual Result Announced for Rainbow Children's Medicare Ltd.

Download PDF

Q3FY23 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Q1FY23 Quarterly Result Announced for Rainbow Childrens Medicare Ltd.

Download PDF

Shareholding Pattern

Summary

Name
Category
Shares
Share %
RAMESH KANCHARLA Promoter 31,517,431 31.0%
CHIRLA DINESH KUMAR PADMARAO Promoter 6,633,310 6.5%
ADARSH KANCHARLA Promoter 6,110,432 6.0%
RAMESH KANCHARLA (KANCHARLA FAMILY TRUST) Promoter 5,205,700 5.1%
CHIRLA PADMARAO DINESH KUMAR (SAI GEETA DINESH TRUST) Promoter 1,040,000 1.0%
ICICI PRUDENTIAL ESG EXCLUSIONARY STRATEGY FUND Institutional 6,070,842 6.0%
DSP NIFTY SMALLCAP 250 ETF Institutional 4,157,196 4.1%
TATA MUTUAL FUND - TATA ELSS FUND Institutional 1,690,480 1.7%
AXIS MUTUAL FUND TRUSTEE LIMITED A/C AXIS MUTUAL F Institutional 1,392,840 1.4%
NIPPON LIFE INDIA TRUSTEE LTD- A/C NIPPON INDIA AG Institutional 1,303,294 1.3%
MOTILAL OSWAL NIFTY SMALLCAP 250 INDEX FUND Institutional 1,282,336 1.3%
FRANKLIN TEMPLETON INVESTMENT FUNDS - FRANKLIN IND Institutional 2,798,426 2.8%
ABU DHABI INVESTMENT AUTHORITY - MONSOON Institutional 2,159,233 2.1%
ASHOKA WHITEOAK ICAV - ASHOKA WHITEOAK INDIA OPPOR Institutional 1,095,355 1.1%
HDFC LIFE INSURANCE COMPANY LIMITED Institutional 1,877,250 1.9%
NAGALAKSHMI DEVINENI Public 1,203,009 1.2%
PODDUTURU PREETHAM KUMAR Public 1,082,900 1.1%

Historical Promoter Summary

Promoter Holding(%)

Historical FII Holdings

FII Holding(%)

Historical MF Holdings

MF Holding(%)

Stocks Comparison
Table Chart

Company name
LTP
Market cap (Cr)
Return (1Y %)
Risk (Std. Dev.)
PE Ratio
Financial Year
Rainbow Childrens Medicare Ltd 1,454.70 14,774.90 -0.16 0.07 50.88 Mar 2026
Apollo Hospitals Enterprise Ltd 8,944.50 128,608.19 13.39 0.05 58.06 Mar 2026
Max Healthcare Institute Ltd 1,049.30 102,129.44 -9.06 0.09 70.47 Mar 2026
Fortis Healthcare Ltd 886.00 66,889.29 -7.96 0.09 61.71 Mar 2026
Aster DM Quality Care Ltd 755.05 65,815.63 22.91 0.08 181.69 Mar 2026
Global Health Ltd 1,499.40 40,314.63 8.85 0.09 73.36 Mar 2026
Narayana Hrudayalaya Ltd 1,928.50 39,410.98 6.72 0.07 48.29 Mar 2026
Krishna Institute of Medical Sciences Ltd 809.85 34,014.23 9.00 0.11 175.16 Mar 2026
Dr Lal Pathlabs Ltd 1,896.90 31,839.24 16.33 0.08 58.24 Mar 2026
Poly Medicure Ltd 1,726.00 17,494.99 -13.55 0.14 55.97 Mar 2026
Vijaya Diagnostic Centre Ltd 1,558.90 16,056.31 48.48 0.12 85.58 Mar 2026
Dr Agarwals Health Care Ltd 500.45 15,865.58 13.98 0.09 85.58 Mar 2026
Syngene International Ltd 369.05 14,897.41 -43.33 0.11 67.50 Mar 2026
Indegene Ltd 600.10 14,457.89 2.44 0.09 35.91 Mar 2026
Metropolis Healthcare Ltd 597.45 12,394.33 16.55 0.07 61.10 Mar 2026
Yatharth Hospital & Trauma Care Services Ltd 1,139.50 10,979.58 42.47 0.15 62.99 Mar 2025
Healthcare Global Enterprises Ltd 708.25 10,574.33 6.08 0.09 317.78 Mar 2026
Jupiter Life Line Hospitals Ltd 280.05 9,180.88 -4.31 0.08 48.89 Mar 2026
Thyrocare Technologies Ltd 555.80 8,846.41 37.98 0.12 50.31 Mar 2026
Indraprastha Medical Corporation Ltd 362.90 3,326.81 -24.52 0.15 17.69 Mar 2026
View More

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events
NSE Announcement

Announcement Under Regulation 30 - Update On Commencement Of Operations At Guntur Andhra Pradesh.

Sep 16, 2026

Update on Commencement of Operations at Guntur Andhra Pradesh.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Sep 11, 2026

Intimation of Schedule of Analyst/Institutional Investor Group Meetings.

Rainbow Childrens Medicare Limited - Analysts/Institutional Investor Meet/Con. Call Updates

Sep 11, 2026

Rainbow Childrens Medicare Limited has informed the Exchange about Schedule of meet of Analyst/Institutional Investors Group Meetings.

Announcement under Regulation 30 (LODR)-Cessation

Aug 31, 2026

Resignation of Senior Management Personnel.

Rainbow Childrens Medicare Limited - Resignation

Aug 31, 2026

RAINBOW: Rainbow Children`s Medicare Limited has informed the Exchange regarding Resignation of Mr. Srinath Metla as Senior Management Personnel of the company w.e.f. September 05, 2026.

Rainbow Childrens Medicare Limited - Resignation

Aug 25, 2026

Rainbow Childrens Medicare Limited has informed the Exchange regarding Resignation of Mr Vikas Maheshwari as Chief Financial Officer of the company w.e.f. August 31, 2026.

Announcement under Regulation 30 (LODR)-Change in Management

Aug 25, 2026

Resignation of Mr. Vikas Maheshwari as Chief Financial Officer of the Company w.e.f. August 31 2026

View More
Ex-Date Purpose Notes
2026-07-30 Quarterly Results
2026-05-23 Audited Results, Final Dividend & A.G.M.
2026-01-28 Quarterly Results
2025-11-13 Quarterly Results
2025-07-26 Quarterly Results
2025-05-24 Audited Results, Final Dividend & A.G.M.
2025-02-09 Quarterly Results & Others To consider other business matters.
2024-10-27 Quarterly Results
2024-08-13 Quarterly Results
2024-05-19 Audited Results & Final Dividend
2024-01-24 Quarterly Results
2023-10-30 Quarterly Results
2023-08-07 Quarterly Results
2023-05-14 Audited Results & Final Dividend
2023-02-09 Quarterly Results
2022-11-03 Quarterly Results
2022-08-08 Quarterly Results
2022-05-27 Audited Results & Final Dividend
View More
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
2026-07-21 3.5 FINAL 2026-07-21 Equity Share
2025-06-27 3 FINAL 2025-06-28 Equity Share
2024-07-23 3 FINAL 2024-07-23 Equity Share
2023-06-22 3 FINAL 2023-06-22 Equity Share
2022-09-07 2 FINAL 2022-09-08 Equity Share
No Data Found
No Data Found
No Data Found

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
Client name
Deal Type
Date
Action
Avg. price
Quantity
Exchange
Bnp Paribas Arbitrage Bulk
2023-09-15
Purchase
1,025.22 1,568 NSE
Bnp Paribas Arbitrage Bulk
2023-09-15
Sell
1,023.22 655,246 NSE
Stichting Depositary Apg Emerging Markets Equity Pool Bulk
2022-12-05
Purchase
735.00 1,511,300 NSE
Government Of Singapore Bulk
2022-12-05
Purchase
735.00 1,446,185 NSE
Icici Prudential Mutual Fund Bulk
2022-12-05
Purchase
735.00 1,253,750 NSE
Abu Dhabi Investment Authority Bulk
2022-12-05
Purchase
741.25 900,000 NSE
Stichting Depositary Apg Emerging Markets Equity Pool Bulk
2022-12-05
Purchase
735.00 745,200 NSE
India Acorn Icav - Ashoka India Opportunities Fund Bulk
2022-12-05
Purchase
735.00 722,000 NSE
Government Of Singapore Bulk
2022-12-05
Purchase
735.00 664,500 NSE
Icici Prudential Mutual Fund Bulk
2022-12-05
Purchase
735.00 516,250 NSE
Cdc Group Plc Bulk
2022-12-05
Sell
735.55 9,632,876 NSE
Cdc India Opportunities Limited Bulk
2022-12-05
Sell
735.00 5,033,236 NSE
View More
Client name
Client Category
Action
Reported to Exchange
Quantity
Post Transaction Holding
Avg. Price
Regulation (Insider/SAST)
Mode
White Oak Capital Management Consultants Llp
Other
Disposal
2026-05-22 2,038,948 2,845,567 SAST 29(2) Others
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2024-11-06 10,000 406,379 1,568.20 Insider Trading Market Sale
Dr. Prashanth K
Designated Person
Disposal
2024-11-06 10,000 10,030 1,603.98 Insider Trading Market Sale
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2024-09-30 5,000 416,379 1,430.64 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2024-09-20 3,500 1,154,106 1,352.02 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2024-09-19 15,600 1,157,606 1,307.33 Insider Trading Market Sale
Dr. Shruthi Reddy Poddutoor
Designated Person
Disposal
2024-09-19 15,000 15,000 1,325.95 Insider Trading Market Sale
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2024-09-17 5,000 421,379 1,335.02 Insider Trading Market Sale
Vikas Maheshwari
KMP
Acquisition
2024-08-28 5,986 5,986 10.00 Insider Trading ESOP
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2024-08-21 19,716 426,379 1,184.91 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2024-08-21 7,000 1,173,206 1,195.55 Insider Trading Market Sale
Sanjeev Sukumaran
KMP
Acquisition
2024-07-22 44,000 44,000 10.00 Insider Trading ESOP
Kancharla Family Trust (Through Dr. Ramesh Kancharla)
Promoter Group
Acquisition
2024-05-29 26,500 5,205,700 1,235.25 Insider Trading Market Purchase
Dr. Ramesh Kancharla
Promoter & Director
Acquisition
2024-05-29 22,777 31,517,431 1,225.43 Insider Trading Market Purchase
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2024-03-30 4,000 446,095 1,250.77 Insider Trading Market Sale
Maddirala Subrahmanyam
Immediate Relative
Disposal
2024-03-05 800 700 1,407.89 Insider Trading Market Sale
Varikutti Madhu Babu
Designated Person
Disposal
2024-02-23 4,500 500 1,259.65 Insider Trading Market Sale
White Oak Capital Management Consultants Llp
Other
Disposal
2023-09-13 2,088,635 5,824,215 SAST 29(2) Market
Kalyani Nulu
Designated Person
Disposal
2023-08-25 2,270 0 1,147.09 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-06-24 5,066 1,180,206 975.18 Insider Trading Market Sale
R Gowrisankar
Designated Person
Disposal
2023-06-21 1,500 39,040 966.00 Insider Trading Market Sale
Mahesh Madduri
Designated Person
Disposal
2023-06-08 49,000 1,000 928.02 Insider Trading Market Sale
Saurabh Anand Bhandari
Designated Person
Disposal
2023-06-08 9,750 250 938.15 Insider Trading Market Sale
Varikutti Madhu Babu
Designated Person
Disposal
2023-05-22 1,340 5,200 921.69 Insider Trading Market Sale
Ranjini Nair
Designated Person
Disposal
2023-05-22 10,000 216 923.41 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-03-23 4,000 1,185,272 740.69 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-03-07 1,900 1,189,272 739.84 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-03-02 5,400 1,191,172 729.11 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-02-24 2,627 1,196,572 755.56 Insider Trading Market Sale
Dr. Shaik Farhan Abdur Rashid
Designated Person
Disposal
2023-02-20 6,202 394,256 768.00 Insider Trading Market Sale
Varikutti Madhu Babu
Designated Person
Disposal
2023-02-20 2,000 6,540 761.91 Insider Trading Market Sale
Dr. Preetham Kumar Poddutoor
Designated Person
Disposal
2023-02-20 2,100 1,199,199 770.68 Insider Trading Market Sale
White Oak Capital Management Consultants Llp
Other
Acquisition
2022-12-09 3,285,988 7,912,850 SAST 29(2) Market
British International Investment Plc & Cdc India Opportunities Ltd
Other
Disposal
2022-12-09 14,666,112 SAST 29(2) Market
Varikutti Madhu Babu
Designated Person
Disposal
2022-11-18 2,000 8,540 871.45 Insider Trading Market Sale
Jayadeep Reddy Jammuladinne
Designated Person
Disposal
2022-11-18 3,918 0 865.97 Insider Trading Market Sale
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2022-11-16 10,000 450,095 819.42 Insider Trading Market Sale
Jayadeep Reddy Jammuladinne
Designated Person
Disposal
2022-11-14 3,000 3,918 849.40 Insider Trading Market Sale
Dr. Maddirala Subrahmanyam
Immediate Relative
Disposal
2022-11-14 15,000 0 794.06 Insider Trading Market Sale
Dr. Pranathi Subrahmanyam Maddirala
Designated Person
Disposal
2022-11-14 40,500 460,095 843.63 Insider Trading Market Sale
View More

About Rainbow Childrens Medicare Ltd

Stock PE (TTM)

50.88

Promoter Holding

49.84%

Book Value

164.3628

ROCE

18.19%

ROE

18.07%

Rainbow Childrens Medicare Limited was originally incorporated as `Rainbow Children`s Medicare Private Limited` as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana. Subsequently, the Company converted into a Public Limited, and name of the Company was changed to `Rainbow Children`s Medicare Limited` via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 23 hospitals and 5 outpatient clinic centers across 9 cities, with a total bed capacity of 2,375 beds. The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services. Its Pediatric Services include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric Quaternary care (including multi-organ transplants); whereas, Obstetrics & Gynecology services include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility treatment. Rainbow has been pivotal in saving thousands of children. Its inpatient specialties for child care includes Neonatology, Pediatric Intensive Care, Neonatal Intensive Care, Neurology, Gastroenterology, Nephrology, Hematology and Oncology, Pediatric Surgery, Cardiology and Nutrition. The Company was founded on a model of full-time, exclusive doctor led, 24/7 pediatric healthcare delivery, and a significant number of doctors have experience with this same model while training in other countries such as the United Kingdom, United States, Canada and Australia. It also established robust patient retrieval services in and around Hyderabad to retrieve neonates and children from nearby districts to the hub hospital in Hyderabad. Apart from this, the Company follow a doctor engagement model whereby, most of the core specialists work exclusively at hospitals on a full-time retainer basis. This model ensures that most of core specialists are available 24/7 at the hospitals, which is particularly important for children`s emergency, neonatal and pediatric intensive care services. Rainbow Children`s Hospital and BirthRight by Rainbow is an exclusive woman and child care hospital with a nationwide footprint. Its full-spectrum, consultant-led woman and child care services are driven by 22 years of experience and have transformed the lives of women and children across the cities of Hyderabad, Vijayawada, Bengaluru, Delhi, Chennai, and Visakhapatnam. In 1999, Dr. Ramesh Kancharla, the founding Promoter of the Company established first pediatric specialty hospital in 1999 with a 50-bed pediatric hospital in Hyderabad, to address the opportunity to provide pediatric healthcare in the City of Hyderabad. The aim was to provide comprehensive neonatal, pediatric intensive care and pediatric sub-specialty services to children. Since then, under the leadership of Dr. Ramesh Kancharla, Founding Promoter, it established reputation as a leader in multi-specialty pediatric services, with strong clinical expertise in managing complex diseases. The Company has also expanded its operations to include obstetrics and gynecology services, whereby it offer comprehensive perinatal services to patients. In 2005, the Company expanded Banjara Hills Facility to Pediatric Tertiary Care Centres. In 2007, the Company established Hospital at Vijayawada. It started perinatal services by providing comprehensive perinatal care which was backed by teamwork, round the clock availability of obstetricians, anesthesiologists, neonatologists and maternal intensive care services. In 2009, the Company established Hospital at Vikrampuri. In 2010, the Company inaugurated Opening of outpatient clinic at Madhapur. It established IVF hub at Madhapur and hospital at Kondapur. In 2015, the Company established hospitals at Hydernagar and Marathalli respectively. In 2016, the Company established Hospitals at Bangalore and Hyderabad. In 2017, Madhukar Rainbow Hospital at New Delhi commenced operations. In 2018, the Company established Hospital at Guindy, in Chennai. During the year 2019, the Company started outpatient and IVF facility at Kondapur. It commenced commenced providing pediatric Quaternary Care Services at Banjara Hills in Hyderabad. In 2020, the Company established hospitals at Bengaluru and Vizag. In May 2021, the Company moved from an old facility to a new facility for its hospital at Vikrampuri, in Hyderabad. During 2021-22, the Company came out with an Initial Public Offering aggregating 29,168,579 Equity Shares, by issuing 51,67,679 Equity Shares through a fresh issue and 24,000,900 Equity Shares through offer for sale. The IPO comprised of raising capital Rs 280 Crore through fresh issue and Rs 1300 crore through offer for sale, which completed in April, 2022 and resulting to this, the Equity Shares of the Company were listed on National Stock Exchange of India Limited (NSE) and BSE Limited effective May 10, 2022. In 2022, the Company started Organ Transplantation work at its Hyderabad Hub. In 2023, the Company inaugurated inaugurated a new hospital with 100 beds in the Financial District of Hyderabad, as well as a 55-bed hospital in Sholinganallur (OMR), Chennai. A brownfield spoke hospital with approximately 80 beds was acquired in Sarjapur, Bengaluru in FY23. The Company commissioned 3 new spoke hospitals including Himayatnagar, Hyderabad; Sarjapur in Bengaluru and Anna Nagar in Chennai in FY24. It expanded 2 existing hospitals by adding a new block at its Hydernagar Hospital in Hyderabad. Further, it established an outpatient clinic at Hennur, Bengaluru. It launched IVF services at 8 hospitals, taking the count to 11 in 2024. In 2025, Company has purchased two new land parcels admeasuring 9,391 Sq Mtr (~2.32 acres) and 4,987.10 Sq Mtr (~1.23 acres), situated in Sector 44 and Sector 56 respectively in Gurugram, Haryana, for setting up two hospitals with a total bed capacity of ~400 beds. Overall, a total of 280 beds were added during FY 2024-25. In FY2025-26, Company acquired Prashanthi Hospital, Warangal in July 2025. It acquired the Pratiksha Hospital, Guwahati with the expansion into Northeast region. It commenced business at the Rajahmundry Hospital across the Coastal Andhra Pradesh. 60 Beds hospital at HRBR, Bengaluru, commenced operations on May 1, 2026. Mahadevpura IVF clinic commenced operations from May 1, 2026. The Company added 440 beds during the year 2026 across the key markets.

Rainbow Childrens Medicare share price as on 21 Sep 2026 is Rs. 1454.7. Over the past 6 months, the Rainbow Childrens Medicare share price has increased by 29.02% and in the last one year, it has decreased by 0.16%. The 52-week low for Rainbow Childrens Medicare share price was Rs. 1084 and 52-week high was Rs. 1610.

Read More
Registered Office  

8-2-120/103/1 Survey No 403, Road No 2 Banjara Hills, Hyderabad, Telangana, 500034

Tel No. 91-40-49695244

Email companysecretary:rainbowhospitals.in

Web http://www.rainbowhospitals.in

Registrars  

KFin Techologies Ltd

Tel No. 91-40-67162222

Email einward.ris:karvy.com

Web www.kfintech.com

Management  

Independent Non Exe. Director

Independent Non Exe. Director

Non Executive Director

Independent Non Exe. Director

Independent Non Exe. Director

Company Sec. & Compli. Officer

Chairman / Executive Director / M D / Promoter

WTD & Executive Director

Listing Info  

543524

RAINBOW

INE961O01016

Jul

Rainbow Childrens Medicare Ltd FAQs

You can buy Rainbow Childrens Medicare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Rainbow Childrens Medicare Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Sep 18, 2026 03:56 PM the closing price of Rainbow Childrens Medicare Ltd was Rs.1,454.70.

The latest PE ratio of Rainbow Childrens Medicare Ltd as of Sep 18, 2026 03:56 PM is 50.88

The latest PB ratio of Rainbow Childrens Medicare Ltd as of Sep 18, 2026 03:56 PM is 8.85

The 52-week high of Rainbow Childrens Medicare Ltd share price is Rs. 1,610.00 while the 52-week low is Rs. 1,084.00

According to analyst recommendations, Rainbow Childrens Medicare Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Sep 18, 2026 03:56 PM, the market cap of Rainbow Childrens Medicare Ltd stood at Rs. 14,773.79 Cr.

Market Outlook

View all